These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8252302

  • 1. Down's syndrome, dementia, and superoxide dismutase.
    Prasher VP, Chung MC.
    Br J Psychiatry; 1993 Oct; 163():552. PubMed ID: 8252302
    [No Abstract] [Full Text] [Related]

  • 2. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
    Furuta A, Price DL, Pardo CA, Troncoso JC, Xu ZS, Taniguchi N, Martin LJ.
    Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical approaches to the pathogenesis of Down's syndrome.
    Balazs R, Brooksbank BW.
    J Ment Defic Res; 1985 Mar; 29 ( Pt 1)():1-14. PubMed ID: 3159898
    [No Abstract] [Full Text] [Related]

  • 4. Increased superoxide dismutase and Down's syndrome.
    Turrens JF.
    Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
    [Abstract] [Full Text] [Related]

  • 5. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
    Tórsdóttir G, Kristinsson J, Hreidarsson S, Snaedal J, Jóhannesson T.
    Pharmacol Toxicol; 2001 Dec; 89(6):320-5. PubMed ID: 11903959
    [Abstract] [Full Text] [Related]

  • 6. Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea.
    Simpson J, Yates CM, Gordon A, St Clair DM.
    J Neurol Neurosurg Psychiatry; 1984 Oct; 47(10):1138-9. PubMed ID: 6239011
    [No Abstract] [Full Text] [Related]

  • 7. Superoxide dismutase and lipoperoxidation in Down's syndrome fetal brain.
    Brooksbank BW, Balázs R.
    Lancet; 1983 Apr 16; 1(8329):881-2. PubMed ID: 6132215
    [No Abstract] [Full Text] [Related]

  • 8. Down's syndrome: increased enzymatic antioxidative defense is accompanied by decreased superoxide anion generation in blood.
    Kedziora J, Błaszczyk J, Sibińska E, Bartosz G.
    Hereditas; 1990 Apr 16; 113(1):73-5. PubMed ID: 2177051
    [Abstract] [Full Text] [Related]

  • 9. Down's syndrome, dementia, and superoxide dismutase.
    Dickinson MJ, Singh I.
    Br J Psychiatry; 1993 Jun 16; 162():811-7. PubMed ID: 8392422
    [No Abstract] [Full Text] [Related]

  • 10. Is the mental deterioration in Down's syndrome linked to impaired terminal degradation of neurofilaments?
    Elomaa E, Virtanen I.
    Med Hypotheses; 1985 Feb 16; 16(2):171-2. PubMed ID: 3157856
    [Abstract] [Full Text] [Related]

  • 11. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.
    Gulesserian T, Seidl R, Hardmeier R, Cairns N, Lubec G.
    J Investig Med; 2001 Jan 16; 49(1):41-6. PubMed ID: 11217146
    [Abstract] [Full Text] [Related]

  • 12. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation.
    Zemlan FP, Thienhaus OJ, Bosmann HB.
    Brain Res; 1989 Jan 02; 476(1):160-2. PubMed ID: 2521568
    [Abstract] [Full Text] [Related]

  • 13. [Dosage effect of the cytoplasmic superoxide dismutase (SOD-1) gene in the erythrocytes of Down's syndrome patients].
    Tamarkina AD, Annenkov GA, Filippov IK, Lamchingiĭn T.
    Genetika; 1977 Jan 02; 13(5):929-32. PubMed ID: 147797
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Leukocyte lysosomal enzymes in Alzheimer's disease and Down's syndrome.
    Kalanj-Bognar S, Rundek T, Furac I, Demarin V, Cosović C.
    J Gerontol A Biol Sci Med Sci; 2002 Jan 02; 57(1):B16-21. PubMed ID: 11773202
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetics of Down's syndrome: overexpression of transfected human Cu/Zn-superoxide dismutase gene and the consequent physiological changes.
    Groner Y, Elroy-Stein O, Bernstein Y, Dafni N, Levanon D, Danciger E, Neer A.
    Cold Spring Harb Symp Quant Biol; 1986 Jan 02; 51 Pt 1():381-93. PubMed ID: 2953545
    [No Abstract] [Full Text] [Related]

  • 19. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome.
    Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y.
    Proc Natl Acad Sci U S A; 1987 Nov 02; 84(22):8044-8. PubMed ID: 2960971
    [Abstract] [Full Text] [Related]

  • 20. [Down's syndrome and dementia].
    Parajuá-Pozo JL, Casis-Arguea S.
    Rev Neurol; 1987 Nov 02; 31(2):126-8. PubMed ID: 10951667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.